Pharmaceutical companyLabelled by claude-haiku-5.5 from the firm's FDA names. It is not an FDA field.. FDA records under its name, each linked to the record.
As of Nov 21, 2026, FDA's public records list LEXENPHARM with 3 drug applications. The most recent is a drug application dated Nov 18, 2024: Arformoterol Tartrate.
Drug approvals, 510(k) clearances, recalls and letters, 2024 to 2026 to date
A hatched bar is a year that is not over, so its count covers only part of the year.
| Nov 18, 2024 | Arformoterol TartrateANDA 218156 | Drug application |
| Oct 22, 2024 | Formoterol FumarateANDA 216426 | Drug application |
| May 3, 2024 | Albuterol SulfateANDA 215571 | Drug application |
Spellings are joined only when they reduce to the same name, or a reviewed source names the same company. Sharing an FDA establishment number (FEI) is not enough: contract sites make products for many firms. Facts marked AI were labelled by a language model from the firm's FDA names; everything else comes from FDA or Wikidata.